MX7215E - Procedimiento para preparar conjugados de vincesina con una immunoglobulina o fragmentos de la misma - Google Patents

Procedimiento para preparar conjugados de vincesina con una immunoglobulina o fragmentos de la misma

Info

Publication number
MX7215E
MX7215E MX829866U MX986682U MX7215E MX 7215 E MX7215 E MX 7215E MX 829866 U MX829866 U MX 829866U MX 986682 U MX986682 U MX 986682U MX 7215 E MX7215 E MX 7215E
Authority
MX
Mexico
Prior art keywords
immunoglobulin
conjugates
vincesin
fragments
preparing
Prior art date
Application number
MX829866U
Other languages
English (en)
Inventor
George Ferdinand Rowland
Robin George Simmonds
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of MX7215E publication Critical patent/MX7215E/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX829866U 1981-01-12 1982-01-11 Procedimiento para preparar conjugados de vincesina con una immunoglobulina o fragmentos de la misma MX7215E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8100847 1981-01-12

Publications (1)

Publication Number Publication Date
MX7215E true MX7215E (es) 1988-01-08

Family

ID=10518931

Family Applications (1)

Application Number Title Priority Date Filing Date
MX829866U MX7215E (es) 1981-01-12 1982-01-11 Procedimiento para preparar conjugados de vincesina con una immunoglobulina o fragmentos de la misma

Country Status (27)

Country Link
EP (1) EP0056322B1 (es)
JP (1) JPS57136529A (es)
KR (1) KR860001149B1 (es)
AT (1) ATE16603T1 (es)
AU (1) AU549495B2 (es)
BG (1) BG40318A3 (es)
CA (1) CA1180660A (es)
CS (1) CS235525B2 (es)
DD (1) DD201447A5 (es)
DE (1) DE3267474D1 (es)
DK (1) DK5982A (es)
EG (1) EG15599A (es)
ES (1) ES508633A0 (es)
FI (1) FI820020L (es)
GB (1) GB2090837B (es)
GR (1) GR75182B (es)
HU (1) HU186025B (es)
IE (1) IE52239B1 (es)
IL (1) IL64722A (es)
MX (1) MX7215E (es)
NZ (1) NZ199421A (es)
PH (1) PH18031A (es)
PL (1) PL128529B1 (es)
PT (1) PT74252B (es)
RO (1) RO82758B (es)
SU (1) SU1069628A3 (es)
ZA (1) ZA82122B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639456A (en) * 1980-06-10 1987-01-27 Omnichem S.A. Vinblastin-23-oyl amino acid derivatives
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
GB2137210B (en) * 1983-03-30 1986-11-19 Lilly Industries Ltd Immunoglobulin conjugates
GR79898B (es) * 1983-03-30 1984-10-31 Lilly Industries Ltd
ATE64396T1 (de) * 1983-04-29 1991-06-15 Omnichem Sa Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB2148299B (en) * 1983-09-01 1988-01-06 Hybritech Inc Antibody compositions of therapeutic agents having an extended serum half-life
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
FI860456A (fi) * 1985-07-16 1987-01-17 Huhtamaeki Oy Laeaeketehdas Le Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning.
EP0232693A3 (fr) * 1985-12-16 1988-04-06 La Region Wallonne Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant
ZA873600B (en) * 1986-05-27 1988-12-28 Lilly Co Eli Immunoglobulin conjugates
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
FR2626882B1 (fr) * 1988-02-08 1991-11-08 Ire Celltarg Sa Conjugues de derives de vinca comportant une chaine detergente en position c-3
US5144012A (en) * 1988-08-08 1992-09-01 Eli Lilly And Company Cytotoxic drug conjugates
US5006652A (en) * 1988-08-08 1991-04-09 Eli Lilly And Company Intermediates for antibody-vinca drug conjugates
US5094849A (en) * 1988-08-08 1992-03-10 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers
US5028697A (en) * 1988-08-08 1991-07-02 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
US5043340A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxhydrazide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2456224A1 (de) * 1974-11-28 1976-08-12 Karl Dr Med Theurer Verwendung von nativen antikoerpern oder von antikoerper-fragmenten mit kovalent gebundenen oder konjugierten zytostatisch und/bzw. oder zytotoxisch wirkenden substanzen fuer die krebstherapie
GB1446536A (en) * 1975-02-21 1976-08-18 Yeda Res & Dev Pharmaceutically active compositions
FR2349335A1 (fr) * 1976-04-28 1977-11-25 Inst Int Pathologie Cellulaire Complexes d'alcaloides bis-indoliques du type vinblastine avec la tubuline, leur procede d'obtention et leur utilisation
US4275000A (en) * 1977-08-22 1981-06-23 National Research Development Corporation Peptide macromolecular complexes
FR2437213A1 (fr) * 1978-09-28 1980-04-25 Cm Ind Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation
JPS55136235A (en) * 1979-04-09 1980-10-23 Teijin Ltd Antitumor protein complex and its preparation

Also Published As

Publication number Publication date
IL64722A (en) 1985-07-31
PT74252A (en) 1982-02-01
PT74252B (en) 1983-08-24
EP0056322B1 (en) 1985-11-21
IE52239B1 (en) 1987-08-19
DE3267474D1 (en) 1986-01-02
KR860001149B1 (ko) 1986-08-18
PH18031A (en) 1985-03-06
PL128529B1 (en) 1984-02-29
GR75182B (es) 1984-07-13
IL64722A0 (en) 1982-03-31
ZA82122B (en) 1983-07-27
AU7927482A (en) 1982-07-22
DD201447A5 (de) 1983-07-20
ES8304149A1 (es) 1983-02-16
NZ199421A (en) 1984-08-24
EP0056322A1 (en) 1982-07-21
RO82758B (ro) 1984-01-30
GB2090837B (en) 1984-07-18
IE820023L (en) 1982-07-12
PL234695A1 (es) 1982-07-19
JPS57136529A (en) 1982-08-23
HU186025B (en) 1985-05-28
GB2090837A (en) 1982-07-21
EG15599A (en) 1986-06-30
CA1180660A (en) 1985-01-08
ES508633A0 (es) 1983-02-16
RO82758A (ro) 1984-01-14
DK5982A (da) 1982-07-13
KR830008684A (ko) 1983-12-12
BG40318A3 (en) 1986-11-14
ATE16603T1 (de) 1985-12-15
CS235525B2 (en) 1985-05-15
SU1069628A3 (ru) 1984-01-23
FI820020L (fi) 1982-07-13
AU549495B2 (en) 1986-01-30

Similar Documents

Publication Publication Date Title
MX7215E (es) Procedimiento para preparar conjugados de vincesina con una immunoglobulina o fragmentos de la misma
GR1000712B (el) Νεα αντισωματα που αντιδρουν με τα ανθρωπινα καρκινωματα.
ATE279946T1 (de) Herstellung und verwendung von immunkonjugaten die eine vl-kette enthalten welche am asn in position 18 glykosyliert ist
ES520692A0 (es) Un procedimiento de preparacion de conjugados inmunoenzimaticos.
DE3885317D1 (de) Makromolekulare Platin-Antitumorverbindungen.
PT81656B (pt) Processo para a preparacao de polissacarideos bacterianos neutros covalentemente modificados, e de conjugados covalentes estaveis desses polissacarideos e de proteinas imunogenicas
DE68923291T2 (de) Antikörper-konjugate mit zwei oder mehr kovalent vernetzten fc-regionen.
IL71366A (en) Immunoglobulin conjugates with vincaleukoblastine derivatives,their production and pharmaceutical compositions containing them
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
EP0397700A4 (en) Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen
FR2432038A1 (fr) Conjugues marques d'hydrazide d'acide naphtalene-1,2-dicarboxylique chimioluminescent et leur procede de preparation
ES2040269T3 (es) Procedimiento para la obtencion de una inmunotoxina.
SE8002602L (sv) Diagnostiskt forfarande